IBDEI0CZ ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12982,1,3,0)
 ;;=3^Bipolar II Disorder
 ;;^UTILITY(U,$J,358.3,12982,1,4,0)
 ;;=4^F31.81
 ;;^UTILITY(U,$J,358.3,12982,2)
 ;;=^5003519
 ;;^UTILITY(U,$J,358.3,12983,0)
 ;;=F34.0^^58^674^24
 ;;^UTILITY(U,$J,358.3,12983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12983,1,3,0)
 ;;=3^Cyclothymic Disorder
 ;;^UTILITY(U,$J,358.3,12983,1,4,0)
 ;;=4^F34.0
 ;;^UTILITY(U,$J,358.3,12983,2)
 ;;=^5003538
 ;;^UTILITY(U,$J,358.3,12984,0)
 ;;=F31.0^^58^674^20
 ;;^UTILITY(U,$J,358.3,12984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12984,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,12984,1,4,0)
 ;;=4^F31.0
 ;;^UTILITY(U,$J,358.3,12984,2)
 ;;=^5003494
 ;;^UTILITY(U,$J,358.3,12985,0)
 ;;=F31.71^^58^674^22
 ;;^UTILITY(U,$J,358.3,12985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12985,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Partial Remission
 ;;^UTILITY(U,$J,358.3,12985,1,4,0)
 ;;=4^F31.71
 ;;^UTILITY(U,$J,358.3,12985,2)
 ;;=^5003511
 ;;^UTILITY(U,$J,358.3,12986,0)
 ;;=F31.72^^58^674^21
 ;;^UTILITY(U,$J,358.3,12986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12986,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Full Remission
 ;;^UTILITY(U,$J,358.3,12986,1,4,0)
 ;;=4^F31.72
 ;;^UTILITY(U,$J,358.3,12986,2)
 ;;=^5003512
 ;;^UTILITY(U,$J,358.3,12987,0)
 ;;=F06.33^^58^674^3
 ;;^UTILITY(U,$J,358.3,12987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12987,1,3,0)
 ;;=3^Bipolar & Related Disorder d/t Med Cond w/ Manic/Hypomanic-Like Episode
 ;;^UTILITY(U,$J,358.3,12987,1,4,0)
 ;;=4^F06.33
 ;;^UTILITY(U,$J,358.3,12987,2)
 ;;=^5003059
 ;;^UTILITY(U,$J,358.3,12988,0)
 ;;=F31.9^^58^674^12
 ;;^UTILITY(U,$J,358.3,12988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12988,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Manic,Unsp
 ;;^UTILITY(U,$J,358.3,12988,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,12988,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,12989,0)
 ;;=F31.9^^58^674^19
 ;;^UTILITY(U,$J,358.3,12989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12989,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Depressed,Unsp
 ;;^UTILITY(U,$J,358.3,12989,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,12989,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,12990,0)
 ;;=F31.89^^58^674^4
 ;;^UTILITY(U,$J,358.3,12990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12990,1,3,0)
 ;;=3^Bipolar & Related Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,12990,1,4,0)
 ;;=4^F31.89
 ;;^UTILITY(U,$J,358.3,12990,2)
 ;;=^5003520
 ;;^UTILITY(U,$J,358.3,12991,0)
 ;;=F31.9^^58^674^5
 ;;^UTILITY(U,$J,358.3,12991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12991,1,3,0)
 ;;=3^Bipolar & Related Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,12991,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,12991,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,12992,0)
 ;;=A81.00^^58^675^8
 ;;^UTILITY(U,$J,358.3,12992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12992,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,12992,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,12992,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,12993,0)
 ;;=A81.09^^58^675^7
 ;;^UTILITY(U,$J,358.3,12993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12993,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,12993,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,12993,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,12994,0)
 ;;=A81.2^^58^675^72
 ;;^UTILITY(U,$J,358.3,12994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12994,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,12994,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,12994,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,12995,0)
 ;;=F01.50^^58^675^46
 ;;^UTILITY(U,$J,358.3,12995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12995,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,12995,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,12995,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,12996,0)
 ;;=F01.51^^58^675^47
 ;;^UTILITY(U,$J,358.3,12996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12996,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,12996,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,12996,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,12997,0)
 ;;=F02.80^^58^675^34
 ;;^UTILITY(U,$J,358.3,12997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12997,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,12997,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,12997,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,12998,0)
 ;;=F02.81^^58^675^35
 ;;^UTILITY(U,$J,358.3,12998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12998,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,12998,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,12998,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,12999,0)
 ;;=G30.9^^58^675^4
 ;;^UTILITY(U,$J,358.3,12999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12999,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,12999,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,12999,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,13000,0)
 ;;=G31.01^^58^675^70
 ;;^UTILITY(U,$J,358.3,13000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13000,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,13000,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,13000,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,13001,0)
 ;;=G94.^^58^675^6
 ;;^UTILITY(U,$J,358.3,13001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13001,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,13001,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,13001,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,13002,0)
 ;;=G31.83^^58^675^18
 ;;^UTILITY(U,$J,358.3,13002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13002,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,13002,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,13002,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,13003,0)
 ;;=G31.89^^58^675^11
 ;;^UTILITY(U,$J,358.3,13003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13003,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,13003,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,13003,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,13004,0)
 ;;=G31.9^^58^675^12
 ;;^UTILITY(U,$J,358.3,13004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13004,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,13004,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,13004,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,13005,0)
 ;;=G23.8^^58^675^10
 ;;^UTILITY(U,$J,358.3,13005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13005,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,13005,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,13005,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,13006,0)
 ;;=G30.0^^58^675^2
 ;;^UTILITY(U,$J,358.3,13006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13006,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,13006,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,13006,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,13007,0)
 ;;=G30.1^^58^675^3
 ;;^UTILITY(U,$J,358.3,13007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13007,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,13007,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,13007,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,13008,0)
 ;;=B20.^^58^675^21
 ;;^UTILITY(U,$J,358.3,13008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13008,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,13008,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,13008,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,13009,0)
 ;;=G10.^^58^675^22
 ;;^UTILITY(U,$J,358.3,13009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13009,1,3,0)
 ;;=3^Huntington's Disease
